60 results on '"Singer-Englar, T."'
Search Results
2. (444) In-Stent Re-Stenosis for Cardiac Allograft Vasculopathy in the Current Era for Heart Transplantation
3. (575) The Outcome of Heart Transplant Patients with Severe Rejection Requiring ECMO Support: Is it Futile
4. (442) High HDL Levels are Associated with Survival Benefit after Heart Transplantation
5. (761) Does Donor Age Impact Outcomes for MCS Patients Undergoing Heart Transplantation
6. (443) Validation of the Cardiac Allograft Vasculopathy (CAV) Trajectory Score after Heart Transplantation
7. (760) Is Chronic Kidney Disease Truly a Contraindication for Total Artificial Heart Candidacy and Subsequent Heart Transplantation
8. (792) Does Right Ventricular Support with Mechanical Assist Devices Compromise Outcome for Heart Transplantation?
9. (174) Do Older LVAD Patients Have Compromised Outcome after Heart Transplantation: Should They Stay as Destination Therapy?
10. The Outcome of West Nile Virus Infection After Heart Transplantation
11. Is Donor/Recipient Cytomegalovirus Mismatch Truly Associated with Increased Risk for Cardiac Allograft Vasculopathy in the Current Era?
12. Does the Degree of Diastolic Dysfunction in the First Year After Heart Transplant Affect Subsequent Outcomes?
13. Sex Differences in Desensitization for Patients Awaiting Heart Transplantation: Is There a Difference?
14. Do Women Truly Have Less Than Optimal Outcome Post-Heart Transplantation Compared to Men
15. Is Delayed Graft Function Worse in Simultaneous Heart-Kidney Transplant vs Kidney Transplant Alone?
16. COVID Pandemic and Social Mitigations Decrease Hospitalizations for Heart Transplant Patients
17. The Effects of Hypomagnesemia Post Heart Transplantation
18. Intra-Aortic Balloon Placement without Inotropes: A Shift in Practice for Higher Urgency Status for Patients Awaiting Heart Transplant?
19. Is Donor Smoking Truly a Risk Factor for the Development of Cardiac Allograft Vasculopathy?
20. What is the Meaning of Culture Negative Leukocytosis Immediately After Heart Transplantation?
21. Are Calcineurin Inhibitor-Free Protocols Safe and Effective in the Long-Term After Heart Transplant?
22. Complexities of Explanting Durable LVADs (Done at Outside Facilities) at the Time of Heart Transplant Surgery
23. Anti-Thymocyte Globulin Protects Against Ischemia Reperfusion Injury in the Immediate Post Heart Transplant Period
24. Sex Disparities in Heart Transplant Waitlist Status After the Donor Heart Allocation Policy Change
25. Is There Heterogeneity on Outcome of Hospitalized Heart Transplant Patients with COVID-19 Infection Across the US?
26. When is Significant Left Ventricular Hypertrophy Acceptable for Donor Heart Selection
27. Is Sacubitril/Valsartan a Risk Factor for Vasoplegia/Primary Graft Dysfunction After Heart Transplantation?
28. Is ATG Induction with Delayed Initiation of CNI Protective of Renal Function in Patients with Mild Renal Insufficiency?
29. Do Temporary Mechanical Circulatory Support Devices Activate Sensitization Pathways in Patients Awaiting Heart Transplantation?
30. Are Markedly Oversized Donor Hearts Associated with Poor Outcome After Heart Transplantation?
31. Severely Underweight: Is It a Risk Factor for Poor Outcomes in Post-Heart Transplant Patients?
32. Who is at Risk for Seizures After Heart Transplantation?
33. Acute Abdomen Complications Immediately Following Heart Transplantation: What Are the Odds?
34. ACEi Use in Select Patients Awaiting Heart Transplant May Be a Risk Factor for the Development of Primary Graft Dysfunction and Vasoplegia
35. Outcomes of Heart Re-Transplantation with Combined Kidney Transplant
36. Treatment and Outcome of AL Amyloid After Heart Transplantation: Is It Viable?
37. Experience with Eculizumab in Highly Sensitized Patients Undergoing Heart Transplantation
38. Warm Ischemic Time in Orthotopic Heart Transplantation: Is Faster Really Better?
39. Outcome of the Development of Early Restrictive Physiology after Heart Transplantation
40. Is a Switch to Cyclosporine from Tacrolimus a Risk in Heart Transplant Recipients?
41. Donor Heart Coronary Calcification: Do We Take This Donor Heart?
42. Does Crossing Historical DSA in Patients Undergoing Heart Transplantation Have Any Impact on Post-Transplant Outcomes?
43. The Clinical Impact of ACEI/ARBs in Heart Transplantation: Perhaps Not All Good
44. Do Heart-Kidney Transplant Candidates on Mechanical Circulatory Support Have Acceptable Outcomes Post-Transplant?
45. Prophylaxis for Chagas Disease Reactivation: Is it Necessary?
46. Use of Declined Donor Hearts: Is Quality Important?
47. Is Older Age (>60 Years) A Contraindication to Combined Heart-Kidney Transplant?
48. The Impact of Renal Dysfunction in Mechanical Circulatory Support Device Patients on Post-Heart Transplant Outcomes
49. Does Liver Surface Nodularity by Non-Invasive Testing Suggesting Cirrhosis Contraindicate Heart Transplant?
50. Post-Transplant Outcome of the Highly Sensitized Patient Awaiting Heart Transplant Treated with Desensitization
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.